Submission Details
| 510(k) Number | K190623 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 11, 2019 |
| Decision Date | May 30, 2019 |
| Days to Decision | 80 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K190623 is an FDA 510(k) clearance for the Cardioblate Pen Surgical Ablation Device, Cardioblate XL Pen Surgical Ablation Device, a Surgical Device, For Cutting, Coagulation, And/or Ablation Of Tissue, Including Cardiac Tissue (Class II — Special Controls, product code OCL), submitted by Medtronic (Minneapolis, US). The FDA issued a Cleared decision on May 30, 2019, 80 days after receiving the submission on March 11, 2019. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 878.4400.
| 510(k) Number | K190623 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 11, 2019 |
| Decision Date | May 30, 2019 |
| Days to Decision | 80 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | OCL — Surgical Device, For Cutting, Coagulation, And/or Ablation Of Tissue, Including Cardiac Tissue |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 878.4400 |
| Definition | Surgical Device For Cutting, Coagulation, And/or Ablation Of Tissue, Including Cardiac Tissue |